Home / Deep Research / Retinal Arterial Tortuosity

Retinal Arterial Tortuosity

Retinal Arterial Tortuosity (Familial Retinal Arteriolar Tortuosity; FRAT/RATOR): Disease Characteristics Research Report

2026-05-06
Falcon MONDO:0008373 Model: Edison Scientific Literature 35 citations

Retinal Arterial Tortuosity (Familial Retinal Arteriolar Tortuosity; FRAT/RATOR): Disease Characteristics Research Report

1. Disease Information

1.1 Overview (current understanding)

Retinal arterial tortuosity (often discussed clinically as familial retinal arteriolar tortuosity, FRAT; also termed retinal arterial tortuosity, RATOR) is a rare, typically autosomal-dominant retinal vasculopathy characterized by marked tortuosity/contortion of second- and third-order retinal arterioles, with relative sparing of first-order arterioles and the venous system; this funduscopic pattern is repeatedly described as pathognomonic in familial forms. (zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolved pages 65-72, gasparini2024multiorganmanifestationsof pages 2-2)

A typical clinical issue is episodic retinal hemorrhage (intraretinal, preretinal/subhyaloid, sub-internal limiting membrane [sub-ILM], and occasionally subretinal/vitreous), causing transient visual impairment often triggered by minor stress, exertion, or Valsalva-like maneuvers; many episodes resolve spontaneously with good visual recovery. (gasparini2024multiorganmanifestationsof pages 2-2, chen2020bilateralandmultiple pages 1-3, saraf2019familialretinalarteriolar pages 3-5)

1.2 Key identifiers and nomenclature

  • MONDO (disease ontology): MONDO_0008373 (“retinal arterial tortuosity”). (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)
  • OMIM: OMIM %180000 for familial retinal arteriolar/arterial tortuosity (historically “%” denoted unknown molecular basis). (vilimelis2015newgenesinvolveda pages 65-72, zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolveda pages 84-91)
  • Related MONDO entry: MONDO_0012726 (“autosomal dominant familial hematuria–retinal arteriolar tortuosity–contractures syndrome”)—a COL4A1/2-associated phenotype class in Open Targets. (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)

Synonyms / alternative names (as used in the literature retrieved here): - Familial retinal arteriolar tortuosity (FRAT) - Familial retinal arterial tortuosity - Retinal arterial tortuosity (RATOR) - fRAT (abbreviation used in some sources) (zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolveda pages 84-91, gasparini2024multiorganmanifestationsof pages 2-2)

ICD-10/ICD-11 / MeSH / Orphanet IDs: Not explicitly provided in the retrieved full-text excerpts; Open Targets indicates Orphanet as a source but did not return an Orphanet disease identifier in the retrieved evidence. (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)

1.3 Evidence source type

The disease knowledge in this report derives primarily from: - Human case reports/series (FRAT clinical phenotype and hemorrhage triggers/outcomes). (chen2020bilateralandmultiple pages 1-3, obayashi2021acaseseries pages 2-4) - Human genetics studies (segregating COL4A1 variant for FRAT). (zenteno2014nextgenerationsequencing pages 4-5) - Model organism mechanistic work (Col4a1 mutant mice with retinal vascular pathology). (alavi2016col4a1mutationscause pages 2-3) - Aggregated disease-level evidence / protocols from a 2024 systematic review + cohort-based management protocol for COL4A1/2-related disease (in which retinal arterial tortuosity is a component feature). (gasparini2024multiorganmanifestationsof pages 19-19)

2. Etiology

2.1 Primary causal factors

Genetic (major): Familial retinal arteriolar/arterial tortuosity is strongly linked to monoallelic pathogenic variants in COL4A1 (and more broadly retinal arterial tortuosity is associated with COL4A1/COL4A2). (zenteno2014nextgenerationsequencing pages 4-5, gasparini2024multiorganmanifestationsof pages 2-2, OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)

Mechanistic concept: COL4A1 encodes the type IV collagen α1 chain, a core component of vascular basement membranes. Glycine substitutions in the collagenous domain can disrupt collagen IV assembly and secretion (see Mechanism section). (zenteno2014nextgenerationsequencing pages 4-5)

2.2 Risk factors (clinical/episode-level)

While disease susceptibility is genetic, episodic hemorrhages are frequently reported to be precipitated by: - Physical exertion / minor trauma (gasparini2024multiorganmanifestationsof pages 2-2, zenteno2014nextgenerationsequencing pages 1-2) - Valsalva-like maneuvers/straining (e.g., running) (chen2020bilateralandmultiple pages 1-3)

In a 13-year-old FRAT patient, hemorrhages occurred after running 800 m, consistent with a Valsalva-like trigger. (chen2020bilateralandmultiple pages 1-3)

2.3 Protective factors / gene–environment interactions

No specific protective factors (genetic or environmental) were identified in the retrieved sources.

Gene–environment interactions are implied by variable expressivity and hemorrhage triggers (exertion/trauma), and by explicit suggestions that environmental factors and/or genetic modifiers influence phenotype (ocular-only FRAT vs multisystem COL4A1 disease). (zenteno2014nextgenerationsequencing pages 4-5, vilimelis2015newgenesinvolveda pages 95-96)

3. Phenotypes (clinical features; HPO suggestions)

A structured phenotype summary is provided in the table artifact below.

Table (click to expand)
Phenotype feature Suggested HPO term(s) Typical onset / course Triggers / modifiers Complications / QoL impact Quantitative data Key notes / citations
Retinal arteriolar tortuosity distribution in familial disease (FRAT/RATOR) Retinal vascular tortuosity [suggest HP term: retinal arteriolar tortuosity if curated]; Abnormality of retinal vasculature (suggested) Often recognized in childhood or early adulthood; usually chronic/stable between hemorrhagic episodes May become clinically relevant during exertion or minor trauma because hemorrhage can occur despite otherwise stable vessel morphology Can predispose to recurrent retinal hemorrhage and transient visual disturbance; funduscopic pattern is considered highly characteristic/pathognomonic Classic pattern: marked tortuosity of second- and third-order retinal arterioles with normal first-order arteries and venous sparing Core diagnostic description repeated across FRAT/COL4A1 literature (zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolved pages 65-72, vilimelis2015newgenesinvolveda pages 84-91, gasparini2024multiorganmanifestationsof pages 2-2, saraf2019familialretinalarteriolar pages 1-2)
EDS-associated retinal arterial tortuosity phenotype Abnormal retinal vasculature; Retinal vascular tortuosity (suggested) Adult cohort described; variable severity from mild to severe Not clearly linked to hypertension or diabetes in the cohort studied Usually an imaging finding; establishes that tortuosity also occurs outside FRAT and may broaden differential diagnosis In 142 EDS patients, 37.3% definite RAT, 10.6% possible RAT, 52.1% no RAT; among definite RAT eyes: 39.2% mild, 40.2% moderate, 20.6% severe; vessel involvement: 84.9% first-order arterioles, 35.8% macular arterioles, 1.9% arteriovenous Important differential: unlike FRAT, EDS-associated RAT commonly involved first-order arterioles (ghoraba2023retinalarterialtortuosity pages 2-5, ghoraba2023retinalarterialtortuosity pages 1-2, ghoraba2023retinalarterialtortuosity pages 5-5)
Retinal hemorrhages: intraretinal / subretinal / premacular-sub-ILM Retinal hemorrhage; Intraretinal hemorrhage; Subretinal hemorrhage; Preretinal hemorrhage / Premacular hemorrhage (suggested) Episodic; often sudden onset with spontaneous resolution over weeks to months Exercise, minor trauma, Valsalva-like maneuvers/straining; running has been reported as a trigger Acute visual loss, central scotoma; occasional ERM after intervention; anxiety/functional limitation during episodes FRAT family reports describe recurrent perifoveal/foveal hemorrhages; in one 13-year-old case: 6 sub-ILM hemorrhages OD (largest ~1.5 DD) and 2 OS (largest 5.5 DD) Hemorrhage is the main vision-threatening event in FRAT; sub-ILM/premacular hemorrhage well documented by fundus/OCT/FFA (vilimelis2015newgenesinvolveda pages 93-95, vilimelis2015newgenesinvolved pages 93-95, chen2020bilateralandmultiple pages 1-3, chen2020bilateralandmultiple pages 3-5, chen2020bilateralandmultiple media c2e15b79)
Transient vision loss / blurred vision / central scotoma Transient visual loss; Blurred vision; Central scotoma (suggested) Usually episodic and linked to hemorrhage rather than progressive neuroretinal degeneration Often precipitated by hemorrhage after exertion or minor trauma Temporary loss of reading/central vision; can be bilateral in severe premacular hemorrhage; long-term prognosis often good if hemorrhage clears Visual acuity in the 2020 case improved from 20/100 OD, 20/160 OS to 20/16 OD, 20/20 OS after combined treatment/observation Most affected individuals are asymptomatic between episodes, but hemorrhage can cause transient marked impairment (saraf2019familialretinalarteriolar pages 1-2, gasparini2024multiorganmanifestationsof pages 2-2, chen2020bilateralandmultiple pages 1-3, chen2020bilateralandmultiple pages 3-5)
Nailbed capillary tortuosity Capillary tortuosity (suggested) Chronic accompanying microvascular finding when present No specific trigger established May indicate extra-retinal microvascular involvement; little direct QoL impact but useful diagnostically Historical reports note marked nailbed capillary tortuosity; one thesis notes abnormal capillary tortuosity threshold >~20%, with one family showing >30% loops affected Supports systemic small-vessel involvement beyond the retina in some families (vilimelis2015newgenesinvolved pages 65-72, vilimelis2015newgenesinvolveda pages 65-72)
Systemic associations: HANAC-spectrum COL4A1 disease Hematuria; Cerebral aneurysm; Muscle cramps; Leukoencephalopathy; Raynaud phenomenon; Arrhythmia (suggested HPO mappings) Variable; penetrance and expressivity are highly heterogeneous, including asymptomatic/oligosymptomatic carriers Likely modified by genotype plus environmental/genetic modifiers Renal disease, aneurysm risk, muscle symptoms, neurologic disease; requires multidisciplinary surveillance In aggregated COL4A1/2 data: retinal arterial tortuosity 58/685 (8.5%); among asymptomatic/oligosymptomatic carriers undergoing ophthalmic workup, retinal vascular tortuosity detected in 5/13 (38.5%) Same COL4A1 p.Gly510Arg variant can present as isolated FRAT or multisystem HANAC-like disease, demonstrating variable expressivity (vilimelis2015newgenesinvolved pages 95-96, gasparini2024multiorganmanifestationsof pages 2-2, gasparini2024multiorganmanifestationsof pages 19-19, vilimelis2015newgenesinvolveda pages 95-96, zenteno2014nextgenerationsequencing pages 4-5)
Brain small-vessel disease / intracerebral hemorrhage / ischemic lesions in COL4A1/2-related disease Intracerebral hemorrhage; Cerebral small vessel disease; Lacunar stroke; Leukoencephalopathy (suggested) Can occur from childhood to adulthood; chronic vasculopathy with risk of hemorrhagic and ischemic events Blood-pressure burden and trauma likely relevant modifiers; monogenic background is primary Major morbidity from stroke, seizures, cognitive/neurologic impairment; retinal arteriolar tortuosity can be a valuable diagnostic clue Literature aggregation in COL4A1/2 disease: stroke 203/685 (29.6%), seizures/epilepsy 199/685 (29.0%), porencephaly/schizencephaly 168/685 (24.5%); case reports include hippocampal infarction and ICH with tortuous retinal arterioles Retinal arteriolar tortuosity is emphasized as a clue that should prompt evaluation for monogenic COL4A1/2 vasculopathy (kim2017familialretinalarteriolar pages 2-4, bouchart2024clinicalreasoninga pages 3-5, gasparini2024multiorganmanifestationsof pages 2-2, gasparini2024multiorganmanifestationsof pages 19-19)
Course and intervention-associated sequelae after premacular hemorrhage Epiretinal membrane; Wrinkling of retinal internal limiting membrane (suggested) Usually recovery after spontaneous resorption or drainage; sequelae may follow laser membranotomy Procedure-related risk with Nd:YAG membranotomy ERM, ILM wrinkling, rarely other iatrogenic macular complications; affects metamorphopsia risk and follow-up needs In the 2020 bilateral case, ERM developed in the left eye despite excellent acuity recovery Supports careful individualized management; observation alone is reasonable for smaller hemorrhages, laser may accelerate recovery in selected large premacular bleeds (chen2020bilateralandmultiple pages 5-5, chen2020bilateralandmultiple pages 1-3, chen2020bilateralandmultiple pages 3-5)

Table: This table summarizes the main clinical phenotype features reported for familial retinal arterial/arteriolar tortuosity and related COL4A1/2-associated presentations, including suggested HPO mappings, course, triggers, complications, and quantitative findings. It is useful for structured knowledge-base curation and differential diagnosis, including comparison with EDS-associated retinal arterial tortuosity.

3.1 Core ocular phenotype (familial FRAT/RATOR)

Definition/diagnostic pattern: “marked contortion of the second- and third-order retinal arteries with no impact on the first-order arteries and the venous system.” (gasparini2024multiorganmanifestationsof pages 2-2)

Hemorrhages and transient visual symptoms: Most affected individuals experience “episodes of transient vision impairment caused by retinal hemorrhage prompted by minor stress or trauma.” (gasparini2024multiorganmanifestationsof pages 2-2)

3.2 Notable differential diagnosis and phenotypic overlap

  • Ehlers–Danlos syndromes (EDS): A 2023 retrospective cohort study found retinal arterial tortuosity (RAT) was common in EDS, with 37.3% definite RAT and 10.6% possible RAT among 142 imaged EDS patients; importantly, EDS-associated RAT frequently involved first-order arterioles (84.9%), which contrasts with classic FRAT affecting second/third-order arterioles. (ghoraba2023retinalarterialtortuosity pages 1-2, ghoraba2023retinalarterialtortuosity pages 5-5)

4. Genetic / Molecular Information

4.1 Causal genes

  • COL4A1 (primary gene for familial FRAT in multiple pedigrees; strong evidence). (zenteno2014nextgenerationsequencing pages 4-5)
  • COL4A2 (associated with retinal arterial tortuosity within the broader COL4A1/2 disease spectrum in aggregated databases). (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)

4.2 Pathogenic variants (examples)

COL4A1 c.1528G>A (p.Gly510Arg), heterozygous missense: - Identified by WES and confirmed by Sanger in affected family members with FRAT; absent in unaffected daughter and in multiple control datasets. (zenteno2014nextgenerationsequencing pages 1-2, zenteno2014nextgenerationsequencing pages 4-5) - Population data in one study: absent from 200 ethnically matched control alleles and ~8,600 exomes in the NHLBI Exome Variant Server. (zenteno2014nextgenerationsequencing pages 4-5) - Genotype–phenotype variability: the same p.Gly510Arg variant previously reported in HANAC syndrome, while in the FRAT pedigree no extra-ocular features were found, supporting variable expressivity. (zenteno2014nextgenerationsequencing pages 4-5)

Variant localization and domain concept: - The p.Gly510Arg substitution lies within a “critical region (residues 498–528) that includes integrin binding sites” in the collagenous domain. (zenteno2014nextgenerationsequencing pages 4-5)

4.3 Functional consequences (molecular)

Glycine substitutions in the collagenous domain are described as disrupting collagen biology: “perturb triple helix assembly, impair secretion of collagen heterotrimers, and cause intracellular accumulation of misfolded proteins.” (zenteno2014nextgenerationsequencing pages 4-5, vilimelis2015newgenesinvolveda pages 95-96)

4.4 Modifier genes / variable expressivity

Multiple sources emphasize that identical COL4A1 mutations can yield ocular-only FRAT vs multisystem disease (HANAC), consistent with modifier effects (genetic background, environment). (vilimelis2015newgenesinvolveda pages 95-96, zenteno2014nextgenerationsequencing pages 4-5)

4.5 Epigenetics / chromosomal abnormalities

No disease-specific epigenetic or chromosomal abnormality evidence was identified in the retrieved texts.

5. Environmental Information

No specific environmental toxins, lifestyle factors, or infectious agents were identified as causal. The major “environmental” role described is episode triggering (exertion/trauma/Valsalva-like stress) for hemorrhage in genetically susceptible individuals. (chen2020bilateralandmultiple pages 1-3, saraf2019familialretinalarteriolar pages 3-5)

6. Mechanism / Pathophysiology

6.1 Mechanistic causal chain (COL4A1/2-related small-vessel fragility)

A unifying model supported by human genetics and mouse data is: 1) COL4A1 pathogenic variant → abnormal type IV collagen network in vascular basement membranes (zenteno2014nextgenerationsequencing pages 4-5) 2) Primary retinal vascular defects (vessel instability/tortuosity, permeability, hemorrhage) (alavi2016col4a1mutationscause pages 7-8, alavi2016col4a1mutationscause pages 2-3) 3) Secondary retinal responses (reactive Müller glia activation; pro-angiogenic factor upregulation; possible neovascular complications in some COL4A1 contexts) (alavi2016col4a1mutationscause pages 7-8) 4) Clinical manifestation as arteriolar tortuosity + hemorrhagic episodes with transient vision loss. (gasparini2024multiorganmanifestationsof pages 2-2, chen2020bilateralandmultiple pages 1-3)

6.2 Evidence from model organisms (mechanistic depth)

In Col4a1 mutant mice, retinal pathology included hemorrhage and angiogenic lesions. Key quantitative findings include: - Retinal pathology (serous chorioretinopathy, hemorrhages, fibrosis or pathogenic angiogenesis) occurred in up to ~90% of mutant eyes depending on age and allele. (alavi2016col4a1mutationscause pages 1-2) - In a large cohort, penetrance increased with age (estimated 36–43% by P21 and 68–88% after 1 month in one line), and “all mutant eyes exhibited abnormal vascular branching and vascular tortuosity” on fluorescein angiography. (alavi2016col4a1mutationscause pages 2-3) - Cell-type dissection: “Conditional expression of mutant Col4a1 in vascular endothelium, but not RPE, phenocopies the retinal defects.” (alavi2016col4a1mutationscause pages 7-8) - Lesion-associated glial response: Müller cell activation (GFAP/vimentin) and elevated pro-angiogenic factors (Vegfa, Pdgfb, Pgf). (alavi2016col4a1mutationscause pages 7-8)

6.3 Pathways / ontology suggestions

GO Biological Process (suggested) - extracellular matrix organization - basement membrane organization - angiogenesis / regulation of VEGF signaling - blood vessel morphogenesis - response to oxidative stress / wound healing (secondary)

Cell types (CL suggestions) - vascular endothelial cell - pericyte (retinal microvasculature) - Müller glial cell (reactive gliosis noted) (alavi2016col4a1mutationscause pages 7-8)

7. Anatomical Structures Affected

7.1 Primary anatomical site

UBERON suggestions - retina (UBERON:0000966) - retinal blood vessel (UBERON term as applicable)

7.2 Secondary / systemic involvement (context-dependent)

Although FRAT is often described as primarily ocular, retinal arteriolar tortuosity can be a clue to broader COL4A1/2 vasculopathy, including cerebral small vessel disease and hemorrhage risk. (bouchart2024clinicalreasoninga pages 3-5)

8. Temporal Development

8.1 Onset

Onset is often described in childhood or early adulthood in familial FRAT. (zenteno2014nextgenerationsequencing pages 1-2)

8.2 Course

9. Inheritance and Population

9.1 Inheritance

Familial FRAT is generally autosomal dominant; one pedigree includes male-to-male transmission and vertical inheritance consistent with AD. (zenteno2014nextgenerationsequencing pages 1-2)

Open Targets annotations for retinal arterial tortuosity and related entries list monoallelic autosomal allelic requirements. (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)

9.2 Epidemiology / prevalence

Robust population prevalence estimates were not found in the retrieved evidence. A historical estimate notes “approximately 100 cases described” (as of the cited older literature compilation), reflecting rarity and likely underdiagnosis. (vilimelis2015newgenesinvolved pages 65-72)

9.3 Penetrance / expressivity

Penetrance and expressivity in COL4A1/2-related disease are explicitly described as highly variable, with asymptomatic/oligosymptomatic carriers detectable by protocolized screening. (gasparini2024multiorganmanifestationsof pages 19-19)

10. Diagnostics

10.1 Clinical diagnosis (ophthalmic)

Diagnosis is commonly made via: - Dilated fundus examination / color fundus photography identifying the characteristic arteriolar pattern (vilimelis2015newgenesinvolved pages 65-72) - Fluorescein angiography (FA) to document vessel anatomy and hemorrhage-related blocked fluorescence and to exclude leakage in some cases (chen2020bilateralandmultiple media c2e15b79, obayashi2021acaseseries pages 2-4) - Optical coherence tomography (OCT) to localize premacular hemorrhage (subhyaloid vs sub-ILM) and follow resolution (chen2020bilateralandmultiple pages 1-3) - OCT angiography (OCTA), including swept-source OCTA, increasingly used to delineate tortuosity and quantify it objectively (saraf2019familialretinalarteriolar pages 1-2, obayashi2021acaseseries pages 4-5)

Real-world imaging example (figure evidence): In a FRAT patient with bilateral premacular hemorrhages, Figure 1 demonstrates tortuous arterioles on fundus photographs and corresponding SD-OCT evidence of dome-shaped sub-ILM hemorrhage. (chen2020bilateralandmultiple media c2e15b79)

10.2 Genetic testing

  • Single-gene testing / targeted panels including COL4A1 can be used; WES identified COL4A1 p.Gly510Arg in one FRAT pedigree. (zenteno2014nextgenerationsequencing pages 4-5)
  • Diagnostic caveat: FRAT-like families can be negative on panels. In one family case series, a targeted NGS panel of 328 genes “found no pathogenic variants … including COL4A1,” and the family declined further testing, suggesting locus heterogeneity, undetected variant types, or limitations of panels. (obayashi2021acaseseries pages 4-5)

10.3 Differential diagnosis (examples)

In the neurologic setting, retinal arteriolar tortuosity is highlighted as a clue to COL4A1/2-related disorders and helps distinguish from other hereditary CSVDs (e.g., CADASIL, CARASIL, Fabry). (bouchart2024clinicalreasoninga pages 3-5)

11. Outcome / Prognosis

11.1 Visual prognosis

Visual prognosis is generally favorable. A case series documented spontaneous resolution of hemorrhage with recovery to 20/20 by 1 year in a teenager, and good outcomes overall with observation. (obayashi2021acaseseries pages 1-2)

A 2019 OCTA-based FRAT report states prognosis is “excellent” with most patients recovering normal acuity after hemorrhage clearance, though some may have mild irreversible impairment due to macular pigment changes. (saraf2019familialretinalarteriolar pages 3-5)

11.2 Systemic prognosis considerations (COL4A1/2 context)

When retinal arteriolar tortuosity occurs in COL4A1/2 vasculopathy, neurologic risks (ICH, cerebral microbleeds, seizures) can dominate morbidity, warranting multidisciplinary evaluation. (bouchart2024clinicalreasoninga pages 3-5)

12. Treatment / Management

12.1 Acute hemorrhage management

MAXO suggestions - Observation / watchful waiting - Laser membranotomy (Nd:YAG) - Patient education / avoidance counseling

12.2 Prevention of hemorrhage episodes

Avoidance of triggering activities (straining/Valsalva-like maneuvers) is commonly recommended in case management. (saraf2019familialretinalarteriolar pages 1-2)

12.3 Multiorgan management (COL4A1/2 carriers)

A 2024 expert protocol proposes baseline and follow-up screening in COL4A1/2 variant carriers, including brain MRI with angiographic sequences, baseline labs (blood count, CK, coagulation indices), and ophthalmologic evaluation with OCT-based monitoring depending on initial severity; prenatal imaging is suggested for pregnancy risk counseling. (gasparini2024multiorganmanifestationsof pages 19-19)

13. Prevention

Primary prevention is not established (genetic). Key prevention concepts are: - Secondary prevention / surveillance for COL4A1/2 carriers via periodic multi-organ evaluation (brain imaging, ophthalmology, lab screening). (gasparini2024multiorganmanifestationsof pages 19-19) - Tertiary prevention: avoid triggers for hemorrhage; control modifiable vascular risks (e.g., blood pressure) in those with COL4A1/2 vasculopathy. (bouchart2024clinicalreasoninga pages 3-5)

14. Other Species / Natural Disease

No naturally occurring veterinary analogs were identified in the retrieved evidence.

15. Model Organisms

A well-developed mechanistic model exists in Col4a1 mutant mice, which recapitulate retinal vascular tortuosity, hemorrhage, and progressive retinopathy; endothelial expression of mutant Col4a1 is sufficient to induce the phenotype. (alavi2016col4a1mutationscause pages 7-8, alavi2016col4a1mutationscause pages 2-3)

16. Recent developments and real-world implementations (prioritizing 2023–2024)

16.1 2023: EDS association study (real-world EHR + imaging repository)

A 2023 Eye study used a large institutional repository (STARR) and multimodal imaging to systematically grade RAT in EDS, providing practical prevalence estimates and a grading framework with intergrader agreement (kappa). It reported 37.3% definite RAT and subclassified severity and vessel distributions. (ghoraba2023retinalarterialtortuosity pages 1-2, ghoraba2023retinalarterialtortuosity pages 2-5)

16.2 2024: Clinical reasoning and diagnostic positioning in Neurology

A 2024 Neurology “Clinical Reasoning” article emphasizes that “retinal arteriolar tortuosity, while not always present, is an important finding that strongly suggests the diagnosis of COL4A1/2-related disorders,” integrating ophthalmic findings into monogenic CSVD workups and highlighting management implications (blood pressure control; avoiding head trauma). (bouchart2024clinicalreasoninga pages 3-5)

16.3 2024: Management protocol for COL4A1/2 disease

A 2024 AJMG Seminars paper proposes an explicit screening/management protocol (brain MRI/MRA, baseline labs, ophthalmology/OCT monitoring, prenatal imaging, genetic counseling). This is a concrete step toward standard-of-care harmonization for COL4A1/2 carriers in which retinal arterial tortuosity is a recognized phenotype component. (gasparini2024multiorganmanifestationsof pages 19-19)

16.4 Clinical trials / prospective implementation

An actively recruiting ClinicalTrials.gov study (NCT07374913; sponsor: Meyer Children’s Hospital IRCCS; posted 2021, currently recruiting) operationalizes multi-organ screening for COL4A1/2 variant carriers in routine care settings with standardized ophthalmological OCT assessments, cardiology testing, and exploratory plasma biomarkers (MMP2/MMP9). (NCT07374913 chunk 1)

Key limitations of the current evidence base

  • FRAT/RATOR remains rare; much evidence comes from case reports/series, limiting precise penetrance and population prevalence estimates. (vilimelis2015newgenesinvolved pages 65-72)
  • Database identifiers (Orphanet/ICD/MeSH) were not recoverable from the retrieved excerpts; additional targeted database queries (OMIM/Orphanet directly) would be needed for full code normalization. (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)
  • COL4A2-specific variant-to-FRAT evidence was limited in the retrieved full texts; associations appear in aggregated resources. (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1)

Identifier normalization artifact

Table (click to expand)
Preferred name Key synonyms / alternative names MONDO ID(s) OMIM identifier Associated gene(s) Typical inheritance Key defining diagnostic description
Retinal arterial tortuosity Retinal arteriolar tortuosity; familial retinal arteriolar tortuosity (FRAT); familial retinal arterial tortuosity; fRAT; retinal arterial tortuosity (RATOR) (zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolveda pages 84-91, gasparini2024multiorganmanifestationsof pages 2-2) MONDO:0008373 = retinal arterial tortuosity; MONDO:0012726 = autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1) OMIM %180000 for familial retinal arteriolar/arterial tortuosity (vilimelis2015newgenesinvolveda pages 65-72, zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolveda pages 84-91) COL4A1 strongly supported; COL4A2 also associated in Open Targets evidence for retinal arterial tortuosity / related syndrome (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1, vilimelis2015newgenesinvolveda pages 84-91, gasparini2024multiorganmanifestationsof pages 2-2) Usually autosomal dominant / monoallelic; vertical transmission and male-to-male transmission reported in families (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1, zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolveda pages 84-91) Marked tortuosity/contortion of second- and third-order retinal arteries/arterioles, typically with normal first-order arteries and sparing of the venous system; funduscopic appearance described as pathognomonic (vilimelis2015newgenesinvolveda pages 65-72, zenteno2014nextgenerationsequencing pages 1-2, vilimelis2015newgenesinvolved pages 65-72, gasparini2024multiorganmanifestationsof pages 2-2)

Table: This table summarizes the principal disease names, identifiers, genes, inheritance, and defining diagnostic features for retinal arterial/arteriolar tortuosity. It is useful as a compact normalization reference for disease knowledge-base curation.

References

  1. (zenteno2014nextgenerationsequencing pages 1-2): Juan C. Zenteno, Jaume Crespí, Beatriz Buentello-Volante, Jose A. Buil, Francisca Bassaganyas, Jose I. Vela-Segarra, Jesus Diaz-Cascajosa, and Maria T. Marieges. Next generation sequencing uncovers a missense mutation in col4a1 as the cause of familial retinal arteriolar tortuosity. Graefe's Archive for Clinical and Experimental Ophthalmology, 252:1789-1794, Sep 2014. URL: https://doi.org/10.1007/s00417-014-2800-6, doi:10.1007/s00417-014-2800-6. This article has 55 citations.

  2. (vilimelis2015newgenesinvolved pages 65-72): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  3. (gasparini2024multiorganmanifestationsof pages 2-2): Simone Gasparini, Simona Balestrini, Luigi Francesco Saccaro, Giacomo Bacci, Giorgia Panichella, Martino Montomoli, Gaetano Cantalupo, Stefania Bigoni, Giorgia Mancano, Simona Pellacani, Vincenzo Leuzzi, Nila Volpi, Francesco Mari, Federico Melani, Mara Cavallin, Tiziana Pisano, Giulio Porcedda, Augusto Vaglio, Davide Mei, Carmen Barba, Elena Parrini, and Renzo Guerrini. Multiorgan manifestations of col4a1 and col4a2 variants and proposal for a clinical management protocol. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Jul 2024. URL: https://doi.org/10.1002/ajmg.c.32099, doi:10.1002/ajmg.c.32099. This article has 21 citations.

  4. (chen2020bilateralandmultiple pages 1-3): Ting Chen, Hongmei Zheng, Yunyun Wang, Junyi Hu, and Changzheng Chen. Bilateral and multiple sub-internal limiting membrane hemorrhages in a familial retinal arteriolar tortuosity patient by valsalva-like mechanism: an observational case report. BMC Ophthalmology, Apr 2020. URL: https://doi.org/10.1186/s12886-020-01413-0, doi:10.1186/s12886-020-01413-0. This article has 8 citations and is from a peer-reviewed journal.

  5. (saraf2019familialretinalarteriolar pages 3-5): Steven S. Saraf, Ariel J. Tyring, Chieh-Li Chen, Thao Phuong Le, Robert E. Kalina, Ruikang K. Wang, and Jennifer R. Chao. Familial retinal arteriolar tortuosity and quantification of vascular tortuosity using swept-source optical coherence tomography angiography. American Journal of Ophthalmology Case Reports, 14:74-78, Jun 2019. URL: https://doi.org/10.1016/j.ajoc.2019.03.001, doi:10.1016/j.ajoc.2019.03.001. This article has 24 citations.

  6. (OpenTargets Search: retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1): Open Targets Query (retinal arterial tortuosity,familial retinal arterial tortuosity-COL4A1, 4 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  7. (vilimelis2015newgenesinvolveda pages 65-72): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  8. (vilimelis2015newgenesinvolveda pages 84-91): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  9. (obayashi2021acaseseries pages 2-4): Tomohiro Obayashi, Aki Kato, Harumitsu Suzuki, Kei Ohashi, Munenori Yoshida, Yu Shibata, Yuichiro Ogura, and Tsutomu Yasukawa. A case series from a single family of familial retinal arteriolar tortuosity with common history of sudden visual loss. American Journal of Ophthalmology Case Reports, 24:101230, Dec 2021. URL: https://doi.org/10.1016/j.ajoc.2021.101230, doi:10.1016/j.ajoc.2021.101230. This article has 2 citations.

  10. (zenteno2014nextgenerationsequencing pages 4-5): Juan C. Zenteno, Jaume Crespí, Beatriz Buentello-Volante, Jose A. Buil, Francisca Bassaganyas, Jose I. Vela-Segarra, Jesus Diaz-Cascajosa, and Maria T. Marieges. Next generation sequencing uncovers a missense mutation in col4a1 as the cause of familial retinal arteriolar tortuosity. Graefe's Archive for Clinical and Experimental Ophthalmology, 252:1789-1794, Sep 2014. URL: https://doi.org/10.1007/s00417-014-2800-6, doi:10.1007/s00417-014-2800-6. This article has 55 citations.

  11. (alavi2016col4a1mutationscause pages 2-3): Marcel V. Alavi, Mao Mao, Bradley T. Pawlikowski, Manana Kvezereli, Jacque L. Duncan, Richard T. Libby, Simon W. M. John, and Douglas B. Gould. Col4a1 mutations cause progressive retinal neovascular defects and retinopathy. Scientific Reports, Jan 2016. URL: https://doi.org/10.1038/srep18602, doi:10.1038/srep18602. This article has 58 citations and is from a peer-reviewed journal.

  12. (gasparini2024multiorganmanifestationsof pages 19-19): Simone Gasparini, Simona Balestrini, Luigi Francesco Saccaro, Giacomo Bacci, Giorgia Panichella, Martino Montomoli, Gaetano Cantalupo, Stefania Bigoni, Giorgia Mancano, Simona Pellacani, Vincenzo Leuzzi, Nila Volpi, Francesco Mari, Federico Melani, Mara Cavallin, Tiziana Pisano, Giulio Porcedda, Augusto Vaglio, Davide Mei, Carmen Barba, Elena Parrini, and Renzo Guerrini. Multiorgan manifestations of col4a1 and col4a2 variants and proposal for a clinical management protocol. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, Jul 2024. URL: https://doi.org/10.1002/ajmg.c.32099, doi:10.1002/ajmg.c.32099. This article has 21 citations.

  13. (vilimelis2015newgenesinvolveda pages 95-96): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  14. (saraf2019familialretinalarteriolar pages 1-2): Steven S. Saraf, Ariel J. Tyring, Chieh-Li Chen, Thao Phuong Le, Robert E. Kalina, Ruikang K. Wang, and Jennifer R. Chao. Familial retinal arteriolar tortuosity and quantification of vascular tortuosity using swept-source optical coherence tomography angiography. American Journal of Ophthalmology Case Reports, 14:74-78, Jun 2019. URL: https://doi.org/10.1016/j.ajoc.2019.03.001, doi:10.1016/j.ajoc.2019.03.001. This article has 24 citations.

  15. (ghoraba2023retinalarterialtortuosity pages 2-5): Hashem H. Ghoraba and Darius M. Moshfeghi. Retinal arterial tortuosity in ehlers–danlos syndromes. Eye, 37:1936-1941, Oct 2023. URL: https://doi.org/10.1038/s41433-022-02278-x, doi:10.1038/s41433-022-02278-x. This article has 4 citations and is from a peer-reviewed journal.

  16. (ghoraba2023retinalarterialtortuosity pages 1-2): Hashem H. Ghoraba and Darius M. Moshfeghi. Retinal arterial tortuosity in ehlers–danlos syndromes. Eye, 37:1936-1941, Oct 2023. URL: https://doi.org/10.1038/s41433-022-02278-x, doi:10.1038/s41433-022-02278-x. This article has 4 citations and is from a peer-reviewed journal.

  17. (ghoraba2023retinalarterialtortuosity pages 5-5): Hashem H. Ghoraba and Darius M. Moshfeghi. Retinal arterial tortuosity in ehlers–danlos syndromes. Eye, 37:1936-1941, Oct 2023. URL: https://doi.org/10.1038/s41433-022-02278-x, doi:10.1038/s41433-022-02278-x. This article has 4 citations and is from a peer-reviewed journal.

  18. (vilimelis2015newgenesinvolveda pages 93-95): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  19. (vilimelis2015newgenesinvolved pages 93-95): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  20. (chen2020bilateralandmultiple pages 3-5): Ting Chen, Hongmei Zheng, Yunyun Wang, Junyi Hu, and Changzheng Chen. Bilateral and multiple sub-internal limiting membrane hemorrhages in a familial retinal arteriolar tortuosity patient by valsalva-like mechanism: an observational case report. BMC Ophthalmology, Apr 2020. URL: https://doi.org/10.1186/s12886-020-01413-0, doi:10.1186/s12886-020-01413-0. This article has 8 citations and is from a peer-reviewed journal.

  21. (chen2020bilateralandmultiple media c2e15b79): Ting Chen, Hongmei Zheng, Yunyun Wang, Junyi Hu, and Changzheng Chen. Bilateral and multiple sub-internal limiting membrane hemorrhages in a familial retinal arteriolar tortuosity patient by valsalva-like mechanism: an observational case report. BMC Ophthalmology, Apr 2020. URL: https://doi.org/10.1186/s12886-020-01413-0, doi:10.1186/s12886-020-01413-0. This article has 8 citations and is from a peer-reviewed journal.

  22. (vilimelis2015newgenesinvolved pages 95-96): J Crespí Vilimelis. New genes involved in rare diseases in ophthalmology. Unknown journal, 2015.

  23. (kim2017familialretinalarteriolar pages 2-4): Tae Hee Kim, Sonia Lee, and Su Jin Lim. Familial retinal arteriolar tortuosity with acute hippocampal infarction. Case Reports in Ophthalmology, 8:185-189, Mar 2017. URL: https://doi.org/10.1159/000456069, doi:10.1159/000456069. This article has 5 citations and is from a peer-reviewed journal.

  24. (bouchart2024clinicalreasoninga pages 3-5): Jean Bouchart, Sacha Weber, Thibault Coste, Marie-Alice Laville, Margaux Loisel, and Ahmad Nehme. Clinical reasoning: a 50-year-old man with intracerebral hemorrhage and tortuous retinal arterioles. Neurology, Sep 2024. URL: https://doi.org/10.1212/wnl.0000000000209796, doi:10.1212/wnl.0000000000209796. This article has 1 citations and is from a highest quality peer-reviewed journal.

  25. (chen2020bilateralandmultiple pages 5-5): Ting Chen, Hongmei Zheng, Yunyun Wang, Junyi Hu, and Changzheng Chen. Bilateral and multiple sub-internal limiting membrane hemorrhages in a familial retinal arteriolar tortuosity patient by valsalva-like mechanism: an observational case report. BMC Ophthalmology, Apr 2020. URL: https://doi.org/10.1186/s12886-020-01413-0, doi:10.1186/s12886-020-01413-0. This article has 8 citations and is from a peer-reviewed journal.

  26. (alavi2016col4a1mutationscause pages 7-8): Marcel V. Alavi, Mao Mao, Bradley T. Pawlikowski, Manana Kvezereli, Jacque L. Duncan, Richard T. Libby, Simon W. M. John, and Douglas B. Gould. Col4a1 mutations cause progressive retinal neovascular defects and retinopathy. Scientific Reports, Jan 2016. URL: https://doi.org/10.1038/srep18602, doi:10.1038/srep18602. This article has 58 citations and is from a peer-reviewed journal.

  27. (alavi2016col4a1mutationscause pages 1-2): Marcel V. Alavi, Mao Mao, Bradley T. Pawlikowski, Manana Kvezereli, Jacque L. Duncan, Richard T. Libby, Simon W. M. John, and Douglas B. Gould. Col4a1 mutations cause progressive retinal neovascular defects and retinopathy. Scientific Reports, Jan 2016. URL: https://doi.org/10.1038/srep18602, doi:10.1038/srep18602. This article has 58 citations and is from a peer-reviewed journal.

  28. (obayashi2021acaseseries pages 4-5): Tomohiro Obayashi, Aki Kato, Harumitsu Suzuki, Kei Ohashi, Munenori Yoshida, Yu Shibata, Yuichiro Ogura, and Tsutomu Yasukawa. A case series from a single family of familial retinal arteriolar tortuosity with common history of sudden visual loss. American Journal of Ophthalmology Case Reports, 24:101230, Dec 2021. URL: https://doi.org/10.1016/j.ajoc.2021.101230, doi:10.1016/j.ajoc.2021.101230. This article has 2 citations.

  29. (obayashi2021acaseseries pages 1-2): Tomohiro Obayashi, Aki Kato, Harumitsu Suzuki, Kei Ohashi, Munenori Yoshida, Yu Shibata, Yuichiro Ogura, and Tsutomu Yasukawa. A case series from a single family of familial retinal arteriolar tortuosity with common history of sudden visual loss. American Journal of Ophthalmology Case Reports, 24:101230, Dec 2021. URL: https://doi.org/10.1016/j.ajoc.2021.101230, doi:10.1016/j.ajoc.2021.101230. This article has 2 citations.

  30. (NCT07374913 chunk 1): Simona Balestrini. COL4A1COL4A2: Study of Pathological Conditions Involving Multiple Organs Caused by Mutations in the COL4A1 and COL4A2 Genes. Meyer Children's Hospital IRCCS. 2021. ClinicalTrials.gov Identifier: NCT07374913